Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
104.20
-1.47 (-1.39%)
May 14, 2025, 2:10 PM - Market open
Axsome Therapeutics Employees
Axsome Therapeutics had 683 employees as of December 31, 2024. The number of employees increased by 138 or 25.32% compared to the previous year.
Employees
683
Change (1Y)
138
Growth (1Y)
25.32%
Revenue / Employee
$632,734
Profits / Employee
-$407,426
Market Cap
5.13B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AXSM News
- 1 day ago - Axsome Therapeutics Enters $570 Million Term Loan and Revolving Credit Facility with Blackstone - GlobeNewsWire
- 8 days ago - Axsome Therapeutics Q1: Marketing-Driven Growth Masks Profitability Concerns - Seeking Alpha
- 9 days ago - Axsome Therapeutics, Inc. (AXSM) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Axsome Therapeutics Clocks Around 60% Topline Growth In Q1 - Benzinga
- 9 days ago - Axsome Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 13 days ago - Axsome Therapeutics and Mental Health America (MHA) Join Voices to Highlight Mental Health Month - GlobeNewsWire
- 22 days ago - Axsome Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Axsome Therapeutics to Report First Quarter 2025 Financial Results on May 5 - GlobeNewsWire